← Daikon Radish

Daikon Radish: Glucosinolates, Digestion, and Liver Health

How daikon radish delivers cancer-protective isothiocyanates through its glucosinolate-myrosinase system, protects the liver from oxidative damage, and supports blood sugar regulation.

Daikon is a large, mild white radish central to Japanese, Korean, and Chinese cooking, and one of the most consumed vegetables in Asia. Beyond being low in calories and high in fiber, daikon contains a two-part chemical system — glucosinolates converted to isothiocyanates by the enzyme myrosinase — that research links to cancer cell apoptosis, liver protection, and blood sugar regulation [1][6]. The specific isothiocyanates in daikon, particularly 4-methylthio-3-butenyl isothiocyanate (GRH-ITC), are chemically distinct from sulforaphane in broccoli and show selective cytotoxic activity against colon cancer cells in laboratory models [1]. Daikon also contains active digestive enzymes — diastase, amylase, and esterase — that assist starch and fat digestion, which is why grated raw daikon is traditionally served alongside fried foods in Japanese cuisine [5]. Its sprouts, known as kaiware-daikon, tested 1.8 times more potent than vitamin C in antioxidant assays, with novel flavanone compounds not found elsewhere in the food supply [4].

How the glucosinolate-myrosinase system works

Daikon's health properties are largely explained by a two-component system unique to cruciferous vegetables. The root stores compounds called glucosinolates in its cells — intact molecules that are largely biologically inert. When the root is cut, grated, or chewed, a separate enzyme (myrosinase) stored in adjacent cells is released and immediately converts glucosinolates into bioactive isothiocyanates, nitriles, and thiocyanates.

The primary glucosinolate in daikon is glucoraphasatin (GRH), which converts to 4-methylthio-3-butenyl isothiocyanate (GRH-ITC). A second abundant glucosinolate, glucoraphenin (GRE), converts to 4-methylsulfinyl-3-butenyl isothiocyanate (GRE-ITC), also called sulforaphene [5]. These are related to but structurally distinct from sulforaphane, the primary active compound in broccoli. Research ranking isothiocyanate content across cruciferous vegetables placed daikon fourth highest overall at approximately 57.6 μmol per 100 g wet weight — meaningfully higher than cabbage, bok choy, or mustard greens [6].

Varietal differences matter substantially. A systematic comparison across Japanese daikon cultivars found total glucosinolate content varying up to 4-fold between high and low varieties, with the ratio of GRH to GRE also differing by variety [5]. Sprout stages consistently showed higher glucosinolate concentrations than mature roots — making kaiware-daikon sprouts the most phytochemically concentrated form.

Cooking inactivates myrosinase before glucosinolates can be converted. Raw daikon, pickled daikon (where bacterial enzymes continue conversion), and daikon sprouts all deliver substantially higher active isothiocyanate content than cooked preparations. Grating or finely chopping immediately before consumption maximizes enzyme-substrate contact.

Cancer-protective mechanisms

GRH-ITC and GRE-ITC from daikon have been shown in laboratory research to act against human cancer cells through multiple simultaneous mechanisms [1][6]:

  • Apoptosis induction: Isothiocyanates activate the intrinsic apoptosis pathway through cytochrome c release and caspase-3 activation, triggering programmed cell death in cancer cells with significantly less effect on normal cells
  • Cell cycle arrest: GRH-ITC arrests cancer cells at the G2/M checkpoint, halting cell division before apoptosis proceeds
  • Phase II enzyme induction: Isothiocyanates activate the Nrf2 transcription factor, upregulating glutathione synthesis, quinone reductase, and detoxification enzymes — the same protective pathway activated by sulforaphane in broccoli
  • Anti-angiogenesis: Daikon bioactives inhibit VEGF signaling and endothelial cell migration, blocking the formation of new blood vessels that growing tumors require [6]

The selectivity for cancer cells over normal cells is clinically relevant. In the Barillari et al. study, cancer cell lines were meaningfully more sensitive to GRH-ITC than normal human colon epithelial cells — suggesting a therapeutic window that laboratory screening of pure cytotoxic compounds often lacks [1].

Liver protection and antioxidant activity

Daikon, and particularly daikon leaves and sprouts, demonstrate hepatoprotective effects in animal research. A 2022 study published in Nutrients showed that radish extract significantly reduced acetaminophen-induced liver damage in mice: liver enzymes (ALT, AST) were lower, lipid peroxidation (MDA) was reduced, and antioxidant enzyme activity (glutathione, superoxide dismutase, catalase) was higher in treated animals [3]. Histological examination confirmed less hepatocyte necrosis and reduced inflammatory infiltration. The protective mechanism was attributed to Nrf2-pathway activation — radish bioactives upregulate the liver's own antioxidant defenses — combined with direct anti-apoptotic effects suppressing caspase-3 in liver tissue.

Kaiware-daikon sprouts show exceptional antioxidant potency. Methanol extract of the sprouts outperformed vitamin C by 1.8-fold in standardized DPPH radical scavenging assays [4]. The active compounds isolated included several sinapinic acid esters (1-O-sinapoyl-β-D-glucose, 1,2-di-O-sinapoyl-β-D-glucose), kaempferol glucosides, and a novel flavanone — 3,5,7-trimethoxy-4'-hydroxy flavanone — first identified in radish sprouts. The sinapic acid esters were the dominant antioxidant fraction. These compounds are distinct from those found in broccoli sprouts, which makes daikon sprouts a complementary rather than redundant source of cruciferous phytochemicals.

Blood sugar and metabolic effects

A 2017 systematic review covering three decades of radish research identified four converging mechanisms by which daikon compounds support blood sugar regulation [2]:

  1. Enzyme inhibition: Isothiocyanates and phenolic compounds inhibit alpha-glucosidase and alpha-amylase in the small intestine, slowing glucose release from dietary carbohydrates
  2. Glucose transporter modulation: Radish compounds affect intestinal GLUT transporters, influencing absorption rate of free glucose
  3. Insulin sensitivity enhancement: Antioxidant activity reduces the oxidative stress that impairs insulin receptor function when chronically elevated
  4. Digestive enzyme activity: Daikon root contains active diastase (a starch-digesting amylase) that aids in carbohydrate digestion — a notably rare presence of a digestive enzyme in a raw vegetable

Daikon has a glycemic index of approximately 15 and contains only about 4 g of digestible carbohydrates per 100 g, making it freely usable in blood sugar management contexts. The review noted that animal studies consistently showed reductions in fasting blood glucose and improvements in insulin sensitivity with radish-supplemented diets, with the mechanisms supported by in vitro evidence, though well-powered human RCTs remain limited [2].

Practical guidance

For maximum isothiocyanate delivery: Use raw, grated daikon (daikon oroshi). Grate immediately before eating rather than in advance, as myrosinase activity diminishes with standing time after cutting. Adding a small amount of mustard seed (which contains active myrosinase) can boost isothiocyanate release from cooked daikon in which endogenous myrosinase has been deactivated.

Daikon sprouts (kaiware-daikon) are the most concentrated source of daikon's active compounds per gram. Use in salads, as a garnish, or on rice bowls. Available in Japanese and Korean grocery stores; easy to grow at home in 5–7 days.

Pickled daikon (takuan in Japanese cuisine, danmuji in Korean) retains meaningful phytochemical content because fermentation provides alternative microbial myrosinase activity. It also delivers lactic acid bacteria. Note that commercially prepared pickled daikon often contains added sugar and food dyes — look for traditionally fermented versions.

Daikon leaves should not be discarded — they contain higher concentrations of the hepatoprotective compounds studied in research than the root itself, and are used in Japanese and Korean cooking as a cooked green [3].

A 100 g serving of raw daikon provides approximately 18 calories, 1.6 g fiber, 22 mg vitamin C (25% DV), 27 mcg folate (7% DV), and potassium, calcium, and phosphorus. It is one of the more nutrient-dense vegetables per calorie available.

See our broccoli page for more on glucosinolates in cruciferous vegetables, our sulforaphane page for a deeper look at Nrf2-pathway activation, and our watercress page for a comparison with another exceptionally isothiocyanate-rich vegetable.

Evidence Review

Kaiware Daikon as Chemopreventive Agent — Barillari et al. (2008) — PMID 18665601

This study from the University of Bologna characterized the cytotoxic and apoptotic activity of kaiware-daikon extract and its purified glucosinolate-derived isothiocyanates against human cancer cell lines. Researchers isolated glucoraphasatin (GRH) and glucoraphenin (GRE) from daikon seeds and sprouts, generated GRH-ITC and GRE-ITC through myrosinase hydrolysis, and tested these compounds against three human colon carcinoma cell lines (HT29, Caco-2, SW480) and normal human colon epithelial cells (NCM460A).

Key findings: Both GRH-ITC and GRE-ITC showed selective cytotoxic and apoptotic activity against all three colon carcinoma cell lines, with IC50 values in the 5–30 μM range depending on compound and cell line. Normal colon epithelial cells were significantly less sensitive, demonstrating a meaningful therapeutic window. The mechanism involved activation of the intrinsic apoptosis pathway — confirmed by cytochrome c release, caspase-3 activation, and PARP cleavage. Cell cycle analysis showed G2/M arrest preceding apoptosis. Whole daikon extract was characterized as "multipotent" because it simultaneously inhibited cell cycle progression, activated apoptosis, and induced phase II detoxification enzymes — three distinct anticancer strategies operating in parallel from a single food source.

Significance: This study provides the highest-resolution mechanistic picture of daikon-specific isothiocyanate activity. GRH-ITC and GRE-ITC are structurally distinct from sulforaphane (which has a methylsulfinyl rather than methylthio side chain) and show complementary but not identical activity profiles, supporting dietary diversity across cruciferous vegetables. The selective toxicity toward cancer versus normal cells is particularly noteworthy. Limitations: in vitro research cannot directly establish human cancer prevention, and the concentrations tested may not be fully achievable through dietary intake alone.

Radish and Diabetes — Banihani (2017) — PMID 28906451

This systematic review from Jordan University of Science and Technology analyzed 30 years of published research (June 1987–May 2017) on Raphanus sativus and diabetes-related outcomes, evaluating in vitro, animal, and available clinical evidence across mechanistic pathways.

Key findings: Evidence across multiple study types converged on four antidiabetic mechanisms: enhanced antioxidant defense reducing oxidative stress in insulin-signaling pathways; hormonal effects on glucose homeostasis; promotion of glucose uptake in peripheral tissues (with preliminary evidence of GLUT4 upregulation); and reduced intestinal glucose absorption through alpha-glucosidase and alpha-amylase inhibition. Animal studies consistently showed reductions in fasting blood glucose and improvements in insulin sensitivity with radish-supplemented diets. In vitro experiments confirmed inhibition of starch-digesting enzymes and glucose-binding capacity of radish leaf preparations. Specific contributing compounds included isothiocyanates, glucosinolates, and phenolic acids.

Significance: This review provides the most comprehensive mechanistic framework available for understanding daikon's blood sugar effects. The explicit limitation — that most supporting evidence comes from cell culture and animal studies, with human clinical trials sparse and often small — is important for calibrating confidence. The review called for rigorous human RCTs before definitive clinical recommendations. The convergence of four independent biological mechanisms substantially strengthens the biological plausibility of the observed effects even in the absence of large human trials.

Hepatoprotective Effects — Hwang et al. (2022) — PMID 36501112

This controlled animal study, published in Nutrients, examined radish extract's ability to protect the liver from acetaminophen-induced acute hepatotoxicity — a well-validated model of oxidative-stress-driven liver damage directly relevant to the most common cause of acute liver failure in high-income countries. Mice received a hepatotoxic dose of acetaminophen, then were treated with standardized radish extract at low and high doses. Liver enzymes (ALT, AST), oxidative stress markers (MDA), antioxidant enzyme activities (glutathione, SOD, catalase), and liver histology were assessed.

Key findings: Radish extract treatment significantly reduced ALT and AST — markers of hepatocyte damage that leak into blood — compared to untreated APAP-injured mice. MDA (lipid peroxidation marker) was significantly lower, indicating less oxidative damage to cell membranes. Glutathione, SOD, and catalase activities were significantly higher in liver tissue of treated animals, reflecting restored endogenous antioxidant capacity. Histological examination confirmed meaningfully less hepatocyte necrosis and reduced inflammatory cell infiltration in radish-treated groups at both doses. The authors identified Nrf2 pathway activation as the primary protective mechanism, with additional anti-apoptotic effects evidenced by suppressed caspase-3 in liver tissue.

Significance: This study provides direct experimental evidence that radish bioactives protect the liver from oxidative damage via Nrf2-mediated antioxidant induction — the same fundamental pathway established as central to cruciferous vegetable hepatoprotection generally. The dose-dependent response and histological confirmation strengthen confidence in the biological reality of the effect. Limitations: animal study with concentrated extract rather than whole food; no long-term or chronic exposure data; human clinical evidence for liver protection remains limited to observational associations.

Antioxidant Constituents of Kaiware-Daikon Sprouts — Takaya et al. (2003) — PMID 14690397

This analytical chemistry study from Nagasaki University identified and characterized the principal antioxidant compounds in radish sprout (kaiware-daikon) using HPLC-guided fractionation and DPPH radical scavenging assays. Systematic fractionation of methanol extract yielded isolated compounds that were structurally characterized by NMR and mass spectrometry.

Key findings: Methanol extract of kaiware-daikon showed antioxidant potency 1.8 times greater than L-ascorbic acid (vitamin C) in standardized DPPH assays. The dominant active compounds were sinapinic acid esters: 1-O-sinapoyl-β-D-glucose and 1,2-di-O-sinapoyl-β-D-glucose. A novel flavanone — 3,5,7-trimethoxy-4'-hydroxy flavanone — was isolated and characterized for the first time from any plant. Kaempferol 3,7-di-O-glucoside and kaempferol 7-O-glucoside were also present. The sinapic acid fraction was quantitatively dominant and responsible for most of the radical scavenging activity.

Significance: This study established the specific antioxidant compound profile of kaiware-daikon sprouts, revealing a composition distinct from other cruciferous sprouts including broccoli and watercress. The novel flavanone represents a compound not encountered in commonly consumed foods, adding to the case for dietary variety across cruciferous vegetables. The antioxidant capacity exceeding vitamin C on a weight basis aligns with broader epidemiological associations between cruciferous vegetable consumption and reduced oxidative stress markers. Standard limitation: in vitro antioxidant assay performance does not directly predict antioxidant bioavailability or activity in vivo after absorption and metabolic transformation.

Glucosinolate-Myrosinase Variability Across Daikon Varieties — Nakamura et al. (2008) — PMID 18345631

This comparative analytical study characterized glucosinolate composition and myrosinase activity across multiple daikon cultivars from different regions of Japan, using HPLC analysis, enzymatic assays, and glucosinolate hydrolysis product identification. The researchers mapped the varietal landscape of the primary chemical system driving daikon's health effects.

Key findings: Glucoraphasatin (GRH) and glucoraphenin (GRE) were confirmed as the dominant glucosinolates across all varieties. Total glucosinolate concentrations varied up to 4-fold between the highest and lowest cultivars. The ratio of GRH to GRE differed substantially by variety, meaning different daikon types produce different proportions of GRH-ITC and GRE-ITC after myrosinase hydrolysis. Myrosinase enzyme activity also varied significantly between varieties. Sprout stages consistently showed higher glucosinolate concentrations than mature roots. The full conversion pathway from glucoraphasatin and glucoraphenin to their respective isothiocyanates was confirmed in situ.

Significance: This study provides the mechanistic foundation for understanding how daikon variety, plant age, and preparation method influence the actual health-relevant compound content delivered at consumption. The 4-fold varietal range in glucosinolate content means that commercial daikon varies substantially in phytochemical potency, though variety information is rarely available to consumers. The consistent finding of higher sprout-stage concentrations is practically important and well-supported. Myrosinase variability further reinforces the recommendation to consume daikon raw and freshly grated, as myrosinase activity is both heat-sensitive and time-sensitive post-cutting.

Bioactive Compounds and Anticancer Mechanisms — Naveed et al. (2025) — PMID 40652415

This comprehensive review in Medical Oncology synthesized the full available literature on Raphanus sativus bioactive compounds and their anticancer mechanisms, covering apoptosis, anti-angiogenesis, cell cycle arrest, autophagy induction, epigenetic modulation, and immune system engagement as distinct research areas.

Key findings: The review identified glucosinolates, isothiocyanates, flavonoids, phenolic acids, anthocyanins (in red daikon varieties), and indole compounds as the principal bioactive classes. Evidence for anticancer activity was documented across liver, prostate, colon, oral, lung, cervical, breast, blood, and gastric cancer models. Anti-angiogenic effects — inhibition of VEGF signaling and endothelial cell migration, preventing tumors from building new blood supplies — were highlighted as a mechanism less well-characterized in most other cruciferous vegetables. Epigenetic effects, including histone deacetylase inhibition and cancer-related gene promoter demethylation, were identified as an emerging research frontier. Daikon's isothiocyanate content (57.6 μmol/100 g wet weight) was ranked fourth highest among cruciferous vegetables. The review explicitly recommended dietary diversity across the cruciferous family rather than reliance on any single vegetable or compound.

Significance: This 2025 review represents the most current synthesis of daikon cancer research, extending beyond isolated compound studies to address epigenetic and angiogenic mechanisms increasingly recognized as central to cancer biology. The consistency of effects across multiple cancer types and multiple independent research groups, and the emergence of anti-angiogenic activity as a daikon-specific property, strengthens confidence in its chemopreventive potential. The review appropriately notes that the majority of evidence remains preclinical and calls for well-designed human prospective and intervention studies — a necessary qualification given that epidemiological evidence for cruciferous vegetable consumption reducing cancer risk in human populations is substantially stronger than daikon-specific clinical trial data.

References

  1. Kaiware Daikon (Raphanus sativus L.) Extract: A Naturally Multipotent Chemopreventive AgentBarillari J, Iori R, Papi A, Orlandi M, Bartolini G, Gabbanini S, Pedulli GF, Valgimigli L. Journal of Agricultural and Food Chemistry, 2008. PubMed 18665601 →
  2. Radish (Raphanus sativus) and DiabetesBanihani SA. Nutrients, 2017. PubMed 28906451 →
  3. Hepatoprotective Effects of Radish (Raphanus sativus L.) on Acetaminophen-Induced Liver Damage via Inhibiting Oxidative Stress and ApoptosisHwang KA, Hwang Y, Hwang HJ, Park N. Nutrients, 2022. PubMed 36501112 →
  4. Antioxidant Constituents of Radish Sprout (Kaiware-daikon), Raphanus sativus LTakaya Y, Kondo Y, Furukawa T, Niwa M. Journal of Agricultural and Food Chemistry, 2003. PubMed 14690397 →
  5. Comparison of the Glucosinolate-Myrosinase Systems among Daikon (Raphanus sativus, Japanese White Radish) VarietiesNakamura Y, Nakamura K, Asai Y, Wada T, Tanaka K, Matsuo T, Okamoto S, Meijer J, Kitamura Y, Nishikawa A, Park EY, Sato K, Ohtsuki K. Journal of Agricultural and Food Chemistry, 2008. PubMed 18345631 →
  6. Bioactive Compounds in Raphanus sativus: Mechanisms of Apoptosis, Anti-Angiogenesis, Cell Cycle Arrest and Beyond in Cancer Prevention and TreatmentNaveed T, Ali S, Summer M. Medical Oncology, 2025. PubMed 40652415 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.